<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Psychiatry Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J Psychiatry Neurosci</journal-id>
<journal-title-group>
<journal-title>Journal of Psychiatry &amp; Neuroscience : JPN</journal-title>
</journal-title-group>
<issn pub-type="ppub">1180-4882</issn>
<issn pub-type="epub">1488-2434</issn>
<publisher>
<publisher-name>Joule Inc.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31094488</article-id>
<article-id pub-id-type="pmc">6710089</article-id>
<article-id pub-id-type="doi">10.1503/jpn.180184</article-id>
<article-id pub-id-type="publisher-id">44-5-350</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Paper</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Truncating variant burden in high-functioning autism and pleiotropic effects of <italic>LRP1</italic> across psychiatric phenotypes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Torrico</surname>
<given-names>Bàrbara</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shaw</surname>
<given-names>Alex D.</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mosca</surname>
<given-names>Roberto</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vivó-Luque</surname>
<given-names>Norma</given-names>
</name>
<degrees>BSc</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hervás</surname>
<given-names>Amaia</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fernàndez-Castillo</surname>
<given-names>Noèlia</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aloy</surname>
<given-names>Patrick</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bayés</surname>
<given-names>Mònica</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fullerton</surname>
<given-names>Janice M.</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Cormand</surname>
<given-names>Bru</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="author-notes" rid="fn1-44-5-350">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Toma</surname>
<given-names>Claudio</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="author-notes" rid="fn1-44-5-350">*</xref>
</contrib>
<aff id="af1-44-5-350">From the Departament de Genètica, Microbiologia i Estadística, Universitat de Barcelona, Spain (Torrico, Vivó-Luque, Fernàndez-Castillo, Cormand, Toma); the Institute of Biomedicine, University of Barcelona, Barcelona, Spain (Torrico, Fernàndez-Castillo, Cormand, Toma); the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain (Torrico, Fernàndez-Castillo, Cormand, Toma); the Institut de Recerca Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain (Torrico, Fernàndez-Castillo, Cormand); the Neuroscience Research Australia, Sydney, NSW, Australia (Shaw, Fullerton, Toma); the School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia (Shaw, Fullerton, Toma); the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Institute of Science and Technology, Barcelona, Spain (Mosca, Aloy); the Child and Adolescent Mental Health Unit, Hospital Universitari Mútua de Terrassa, Spain (Hervás); the Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (Aloy); and the Centro Nacional de Análisis Genómico (CNAG), Barcelona, Spain (Bayés)</aff>
</contrib-group>
<author-notes>
<corresp id="c1-44-5-350">Correspondence to: B. Cormand, Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, 08028 Barcelona, Spain, <email>bcormand@ub.edu</email>; C. Toma, Neuroscience Research Australia, Margarete Ainsworth Building, Barker Street, Randwick NSW 2031, Sydney, Australia, <email>c.toma@neura.edu.au</email></corresp>
<fn id="fn1-44-5-350">
<label>*</label>
<p>These authors contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement" id="fn2-44-5-350">
<p><bold>Competing interests:</bold> None declared.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>16</day>
<month>5</month>
<year>2019</year>
</pub-date>
<volume>44</volume>
<issue>5</issue>
<fpage>350</fpage>
<lpage>359</lpage>
<history>
<date date-type="received">
<day>10</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>21</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>26</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>2</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 Joule Inc. or its licensors</copyright-statement>
<copyright-year>2019</copyright-year>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Previous research has implicated de novo and inherited truncating mutations in autism-spectrum disorder. We aim to investigate whether the load of inherited truncating mutations contributes similarly to high-functioning autism, and to characterize genes that harbour de novo variants in high-functioning autism.</p>
</sec>
<sec>
<title>Methods</title>
<p>We performed whole-exome sequencing in 20 high-functioning autism families (average IQ = 100).</p>
</sec>
<sec>
<title>Results</title>
<p>We observed no difference in the number of transmitted versus nontransmitted truncating alleles for high-functioning autism (117 v. 130, <italic>p</italic> = 0.78). Transmitted truncating and de novo variants in high-functioning autism were not enriched in gene ontology (GO) or Kyoto Encyclopedia of Genes and Genomes (KEGG) categories, or in autism-related gene sets. However, in a patient with high-functioning autism we identified a de novo variant in a canonical splice site of <italic>LRP1</italic>, a postsynaptic density gene that is a target for fragile X mental retardation protein (FRMP). This de novo variant leads to in-frame skipping of exon 29, removing 2 of 6 blades of the β-propeller domain 4 of <italic>LRP1</italic>, with putative functional consequences. Large data sets implicate <italic>LRP1</italic> across a number of psychiatric disorders: de novo variants are associated with autism-spectrum disorder (<italic>p</italic> = 0.039) and schizophrenia (<italic>p</italic> = 0.008) from combined sequencing projects; common variants using genome-wide association study data sets from the Psychiatric Genomics Consortium show gene-based association in schizophrenia (<italic>p</italic> = 6.6 × E<sup>−07</sup>) and in a meta-analysis across 7 psychiatric disorders (<italic>p</italic> = 2.3 × E<sup>−03</sup>); and the burden of ultra-rare pathogenic variants has been shown to be higher in autism-spectrum disorder (<italic>p</italic> = 1.2 × E<sup>−05</sup>), using whole-exome sequencing from 6135 patients with schizophrenia, 1778 patients with autism-spectrum disorder and 7875 controls.</p>
</sec>
<sec>
<title>Limitations</title>
<p>We had a limited sample of patients with high-functioning autism, related to difficulty in recruiting probands with high cognitive performance and no family history of psychiatric disorders.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Previous studies and ours suggest an effect of truncating mutations restricted to severe autism-spectrum disorder phenotypes that are associated with intellectual disability. We provide evidence for pleiotropic effects of common and rare variants in the <italic>LRP1</italic> gene across psychiatric phenotypes.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>